Colin David Eldred

USPTO Granted Patents = 17 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 120(Granted Patents)

Location History:

Ware, GB (1988 - 1995)
Hertford, GB (1999)
Herts, GB (1999)
Stevenage, GB (2002 - 2012)

Company Filing History:

Smithkline Beecham Corporation

Years Active: 1988-2012

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8329730 - Compounds (2012-12-11),

2. 8093281 - Indazoles as glucocorticoid receptor ligands (2012-01-10),

3. 7622464 - Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases (2009-11-24),

4. 7566786 - Quinoline derivatives as phosphodiesterase inhibitors (2009-07-28),

5. 7157457 - Compounds useful in the treatment of inflammatory diseases (2007-01-02),

6. 7101882 - Morpholin-acetamide derivatives for the treatment of inflammatory diseases (2006-09-05),

7. 6740644 - Chemical compounds (2004-05-25),

8. 6677316 - Adenosine derivatives and methods of administration (2004-01-13),

9. 6544960 - Chemical compounds (2003-04-08),

10. 6492348 - Adenosine derivatives (2002-12-10),

11. 6455510 - Chemical Compounds (2002-09-24),

12. 5998388 - Adenosine derivatives (1999-12-07),

13. 5861414 - Piperidineacetic acid derivatives useful as fibrinogen antagonist agent (1999-01-19),

14. 5389659 - C-linked pyrazole derivatives (1995-02-14),

15. 5252593 - Pyrazole containing benzofuran derivatives and pharmaceutical (1993-10-12),

Title: Colin David Eldred: A Pioneer in Pharmaceutical Innovations

Introduction

Colin David Eldred is a distinguished inventor based in Stevenage, GB, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 17 patents, Eldred has made strides in developing novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Eldred has focused on compounds that relate to novel oxadiazole derivatives, which exhibit pharmacological activity. These inventions include processes for their preparation, pharmaceutical compositions containing them, and their use in treating various disorders. Additionally, he has worked on indazoles as glucocorticoid receptor ligands, showcasing his innovative approach to drug development.

Career Highlights

Eldred has had a notable career, working with prominent companies such as Glaxo Group Limited and SmithKline Beecham Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Eldred has collaborated with several professionals in his field, including Andrew Michael Kenneth Pennell and Stephen Swanson. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Colin David Eldred's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to influence the development of new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

1 patent pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.